Marino, Stram & Associates LLC Eli Lilly & CO Transaction History

Marino, Stram & Associates LLC

$446 Million
Q1 2025

A detailed history of Marino, Stram & Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Marino, Stram & Associates LLC holds 3,842 shares of LLY stock, worth $2.83 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

3,842

Previous 2,856 34.52%

Holding current value

$2.83 Million

Previous $2.2 Million 43.97%

% of portfolio

0.71%

Previous 0.5%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	BUY	$725.72 - $929.72 $715,559 - $916,703	986 Added 34.52%	3,842 $3.17 Million
Q4 2024 Jan 17, 2025	BUY	$727.2 - $932.06 $10,180 - $13,048	14 Added 0.49%	2,856 $2.2 Million
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $21,619 - $26,880	28 Added 1.0%	2,842 $2.52 Million
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $13,772 - $17,271	19 Added 0.68%	2,814 $2.55 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $8,290 - $11,091	-14 Reduced 0.5%	2,795 $2.17 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $5,251 - $6,191	10 Added 0.36%	2,809 $1.64 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $8,259 - $11,386	19 Added 0.68%	2,799 $1.5 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $70,513 - $82,814	227 Added 8.89%	2,780 $954,000
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $18,006 - $20,981	-56 Reduced 2.15%	2,553 $0
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.04%	2,609 $843,000
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $2,508 - $2,945	9 Added 0.35%	2,608 $846,000
Q1 2022 Apr 25, 2022	BUY	$234.69 - $291.66 $53,744 - $66,790	229 Added 9.66%	2,599 $744,000
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $87,241 - $108,267	388 Added 19.58%	2,370 $655,000
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $439,211 - $540,511	1,982 New	1,982 $458,000
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $281,838 - $364,555	-1,561 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$164.32 - $212.72 $164 - $212	1 Added 0.06%	1,561 $292,000
Q3 2020 Oct 22, 2020	BUY	$146.22 - $169.13 $146 - $169	1 Added 0.06%	1,560 $231,000
Q2 2020 Jul 20, 2020	BUY	$136.42 - $164.18 $15,142 - $18,223	111 Added 7.67%	1,559 $256,000
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $10,357 - $12,819	-87 Reduced 5.67%	1,448 $201,000
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $164,122 - $203,280	1,535 New	1,535 $202,000
Q2 2019 Jul 19, 2019	SELL	$110.79 - $129.32 $179,590 - $209,627	-1,621 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $12,466 - $14,674	112 Added 7.42%	1,621 $210,000
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $8,163 - $9,636	110 Added 7.86%	1,509 $117,000
Q4 2017 Mar 09, 2018	BUY	$81.94 - $87.89 $114,634 - $122,958	1,399	1,399 $118,000

Others Institutions Holding LLY

# of Institutions

4,388

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $701B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.

Account

Marino, Stram & Associates LLC Eli Lilly & CO Transaction History